AFLURIA QUADRIVALENT Trademark

Trademark Overview

On Tuesday, November 14, 2017, a trademark application was filed for AFLURIA QUADRIVALENT with the United States Patent and Trademark Office. The USPTO has given the AFLURIA QUADRIVALENT trademark a serial number of 87684481. The federal status of this trademark filing is REGISTERED as of Tuesday, February 12, 2019. This trademark is owned by CSL Limited. The AFLURIA QUADRIVALENT trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for the prevention or treatment of influenza; vaccines for human use; influenza vaccines
afluria quadrivalent

General Information

Serial Number87684481
Word MarkAFLURIA QUADRIVALENT
Filing DateTuesday, November 14, 2017
Status700 - REGISTERED
Status DateTuesday, February 12, 2019
Registration Number5676287
Registration DateTuesday, February 12, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements

Goods and Servicespharmaceutical preparations and substances for the prevention or treatment of influenza; vaccines for human use; influenza vaccines
Disclaimer with Predetermined Text"QUADRIVALENT"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 27, 2017
Primary Code005
First Use Anywhere DateWednesday, January 4, 2017
First Use In Commerce DateWednesday, January 4, 2017

Trademark Owner History

Party NameCSL Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressParkville 3052
AU
Party NameCSL Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressParkville 3052
AU
Party NameCSL Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressParkville 3052
AU

Trademark Events

Event DateEvent Description
Monday, February 12, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, November 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 12, 2019REGISTERED-PRINCIPAL REGISTER
Friday, January 11, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, January 10, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, December 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 21, 2018STATEMENT OF USE PROCESSING COMPLETE
Thursday, December 6, 2018USE AMENDMENT FILED
Friday, December 21, 2018SOU EXTENSION 1 GRANTED
Wednesday, December 12, 2018SOU EXTENSION 1 FILED
Friday, December 21, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 17, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 17, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 12, 2018SOU TEAS EXTENSION RECEIVED
Thursday, December 6, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 6, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, June 12, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 5, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 1, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, March 1, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 1, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, March 1, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 27, 2018ASSIGNED TO EXAMINER
Monday, November 27, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 17, 2017NEW APPLICATION ENTERED

Related Keywords

quadrivalent afluria influenza vaccines human treatment prevention preparations substances pharmaceutical